Supporting life science companies in their relentless pursuit of quality manufacturing is PharmEng Technology, a global full-service consulting firm that serves the pharmaceutical, biotechnology, medical device, and cannabis industries. It is a full-service firm with a talent pool of over 250 seasoned engineers and consultants serving clients across the Americas, Europe, and Asia.
PharmEng's services suite comprises regulatory and quality compliance, unrivaled product testing capabilities, toxicology assessments, and robust and scalable manufacturing. Apart from these, it offers dedicated training to boost a client's operations and ability to develop cost-effective and premium healthcare products. PharmEng provides comprehensive technical know-how to process, utility, mechanical, and automation engineers and PMP-certified project managers within client organizations.
Its suite is designed for deployment across various product life cycle stages, including phases I, II, and III of product development, pre-market and post-market support, pre-conceptual and detailed design stages, Commission, Qualification & Validation (CQV), and final handover for commercial manufacturing. Furthermore, PharmEng provides temperature (thermal) mapping services to assist businesses in monitoring and maintaining the efficacy of temperature-controlled storage systems. It creates standards and techniques for performing thermal process ratings tailored to governmental standards and specifications and regulatory standards. At the same time, PharmEng offers reliable project control tools, resource planning, and communication across all stakeholders under its project management services.
Its specialized Commission, Qualification, and Validation (CQV) services are performed by American Society for Quality (ASQ)-certified professionals and auditors.
"Our engineers are adept at creating scalable and reliable pharmaceutical production facilities and processes utilizing cutting-edge methodologies to meet and surpass operational and regulatory standards," says Dharti Pancholi, Executive Vice President and Global Managing Director of PharmEng Technology.
PharmEng adopts a cross-functional collaboration approach to serve its clientele, which ranges from large publicly-traded corporations to small startup companies across the globe. Since its inception, it has supported numerous cell and gene therapy, antibody vaccine, and biologics companies. PharmEng has built a track record of driving vaccine development funds, offering its services to contract manufacturing organizations (CMOs) and small therapeutics companies seeking US expertise.
Its global reach and commitment to providing highcaliber and compliant services set PharmEng apart from its rivals. Unlike businesses that only offer specialty services like commissioning, certification, validation, regulatory support, or services associated with the product life cycle, PharmEng provides an end-to-end portfolio that holistically supports client projects.
Our engineers are adept at creating scalable and reliable pharmaceutical production facilities and processes utilizing cutting-edge methodologies to meet and surpass operational and regulatory standards
Moving forward, it aims to continue offering rapid, reliable, and high-quality consulting services to assist clients in finding cost-effective and efficient solutions that ensure the timely and efficient development of superior pharma products.